The Global Biopharmaceutical Logistics Market is set to experience robust of USD 125.47 billion and it is projected to grow at the CAGR of 5.93% during the forecast period 2024-2032, driven by the increasing adoption of temperature-regulated transportation for critical drugs and therapeutics. The market is bolstered by the rising need for efficient supply chains, advanced cold chain infrastructure, and next-generation technologies, all of which support the production and distribution of biologics, vaccines, and other temperature-sensitive products. According to a study by EY-FICCI, the growing burden of diseases such as cancer is expected to fuel the demand for efficient diagnostics and therapeutics, further emphasizing the need for robust logistics solutions to maintain the integrity of these treatments during transportation.
As the biopharmaceutical landscape evolves, the complexities associated with handling biologics, hormone medications, and temperature-specific byproducts are leading to a surge in demand for specialized cold chain logistics. Additionally, the increased focus on time-sensitive deliveries and efficient last-mile services reflects the commitment of logistics providers to meet healthcare demands promptly and maintain patient welfare. Furthermore, the market benefits from rising investments in cold chain infrastructure, especially since the onset of the COVID-19 pandemic, as well as advancements in digital technologies for tracking and monitoring. However, the industry faces challenges in the form of stringent regulatory compliance, rising operational costs, and the need to maintain uninterrupted supply chains amid global disruptions.
The cold chain logistics segment is expected to see a significant boost through 2032, driven by the rising production of temperature-controlled biologics and pharmaceutical products. The integration of telematics and other advanced technologies in cold chain logistics is enhancing safety and efficiency across the biopharmaceutical supply chain.
The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. Additionally, the Asia-Pacific region is forecasted to witness notable growth due to the rising geriatric population and the solid presence of pharmaceutical giants in countries such as China and India.
Major Market Players Included in This Report Are:
DHL International GmbH
FedEx Corporation
UPS (United Parcel Service, Inc.)
Kuehne + Nagel International AG
DB Schenker
AmerisourceBergen Corporation
XPO Logistics, Inc.
C.H. Robinson Worldwide, Inc.
Agility Public Warehousing Company K.S.C.P.
Ceva Logistics
Panalpina Welttransport Holding AG
Yusen Logistics Co., Ltd.
SF Express Co., Ltd.
DHL Supply Chain
Biocair International Ltd.
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand-side and supply-side analysis of the market.
